Page last updated: 2024-08-21

pyrazines and Esophageal Squamous Cell Carcinoma

pyrazines has been researched along with Esophageal Squamous Cell Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Han, M; He, J; Li, J; Liu, C; Liu, Q; Yuan, H; Zhou, X1
Du, W; Gao, A; Guo, M; Herman, JG; Jiao, S; Wang, L; Zhang, L1
Chen, K; Chen, W; Jin, J; Li, D; Mao, W; Su, D; Wu, J; Ying, L; Yu, H; Zhang, F; Zhang, N1

Other Studies

3 other study(ies) available for pyrazines and Esophageal Squamous Cell Carcinoma

ArticleYear
ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production.
    Biochemical and biophysical research communications, 2021, 01-01, Volume: 534

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Endoplasmic Reticulum Stress; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Male; Mice, Inbred BALB C; Pyrazines; Reactive Oxygen Species

2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
    Cancer science, 2021, Volume: 112, Issue:7

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; DNA Repair; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; GPI-Linked Proteins; Heterografts; Humans; Male; Methylation; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyrazines; Pyrazoles; TOR Serine-Threonine Kinases; Tumor Burden

2021
Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor-κB signaling in esophageal squamous cell carcinoma.
    Cancer medicine, 2017, Volume: 6, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Interleukin-6; Interleukin-8; NF-kappa B; Phenylenediamines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyrazines; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2017